PRESS RELEASE: 17:00, 17 October 2000 Included in this email are: 1. A press release concerning the *Christopher Moraka Defiance Campaign Against Patent Abuse* which aims to bring generic medication to South Africa for patented drugs on which excessive profiteering has taken place. 2. A call to organisations and individuals to endorse the defiance campaign. Do so by emailing info@tac.org.za with the word "Endorse Defiance Campaign" in the subject header. 3. A sourced and verified comparison of the prices of patented versus generic essential medications. TAC member Christopher Moraka lived openly with HIV and recently died of AIDS. He suffered severely from systemic thrush and couldn't afford to buy treatment for it. The defiance campaign has been named after him because he testified about the price of fluconazole before the parliamentary enquiry into pharmaceutical pricing earlier this year. He was one of thousands of South Africans affected by Pfizer's excessive profiteering. If you wish to make a donation to the defiance campaign: Account number: Nedbank Cape Town 1009 726 269 (branch code: 1009 09) Account Name: TAC Co-operative Account North American subscribers can make a tax-exempt donation to the defiance campaign by sending a cheque made out to: South Africa Development Fund 555 Amory Street Boston, MA 02130 Tel: 617 522-5511 e-mail: freesa@igc.org Make checks payable to the South Africa Development Fund and indicate the funds are for the TAC Christopher Moraka Defiance Campaign. 100% of the donation will go to purchasing and distributing medication via qualified health professionals only, free of charge to patients. TAC DOES NOT ACCEPT MONEY FROM PHARMACEUTICAL COMPANIES! *********************** DEFIANCE CAMPAIGN AGAINST PATENT ABUSE AND AIDS PROFITEERING BY DRUG COMPANIES DEFY TRADE LAWS THAT PLACE PROFITS BEFORE HEALTH We are faced with the choice of watching our children, families, friends, neighbours and strangers die because medicines that can save their lives cost too much, or, defying unjust trade laws that protect AIDS profiteering by multinational companies. The choice is clear. The rights to life and access to healthcare are non-negotiable. Profiteering at the expense of life, even when protected by law, is not a right. In March 2000, TAC challenged Pfizer to lower its price for fluconazole to R4.00 per 200mg capsule (still double the generic price). After TAC's campaign started, Pfizer had announced a donation of fluconazole for cryptococcal meningitis free for all people with HIV/AIDS who could not afford the drug. Pfizer has made its donation a public relations exercise to disguise profiteering. Daily people are still dying because of conditions that are treatable and preventable with fluconazole – yet, Pfizer has not yet finalized its agreement with the Ministry of Health, neither has it met the Health Minister's request for a lower price. On 13 July 2000, TAC announced its Defiance Campaign Against Patent Abuse and AIDS Profiteering at the International AIDS Conference in Durban. As part of this campaign, TAC organised a visit to Thailand, where the new rules of the WTO are not yet enforced, and where many essential drugs can still be produced as generics. The aim of this visit was to buy generic fluconazole (a drug that is patented by Pfizer) to improve and prolong the lives of people with HIV/AIDS. The Thailand visit exposed the profiteering and patent abuse by Pfizer. SA PUBLIC SECTOR SA PRIVATE SECTOR THAILAND FLUCONAZOLE R28.57 200mg capsule R80.24 X 200mg capsule R1.78 X 200mg capsule TAC challenges Pfizer, the drug companies and their parent body, the Pharmaceutical Manufacturers Association to take action against us for defying their patent on fluconazole, and, preparing to defy patents on all HIV/AIDS drugs. TAC will stop defying the unjust trade laws with fluconazole once Pfizer has lowered the price to under R4.00 and its "donation" is implemented with no restrictions. TAC has begun to establish a network of doctors and pharmacists who will prescribe high quality low cost generic medicines that are imported from countries such as Thailand and Brazil. We ask all doctors to place their patients before patents. TAC asks Minister Alec Erwin to give the full support of his Ministry and Department to the Defiance Campaign and to the Minister of Health's efforts to make healthcare accessible and affordable to all people. TAC asks all civil society organizations to endorse and help develop the Defiance Campaign against Patent Abuse and AIDS Profiteering. ********************** DEFY TRADE LAWS THAT PLACE PROFITS BEFORE HEALTH In 1997 there were more than 12 000 deaths related to tuberculosis (TB). Last year more than 120 000 people died as a result of AIDS. The health crisis facing South Africa is getting worse. · On October 11th 2000, Business Day reported that: "A funeral parlour in Alexandra buries on average between 50 and 100 people a weekend who are known to have died of AIDS-related sickness." · The Educator's Voice, a paper produced by the South African Democratic Teachers Union (SADTU) reports nearly 400 AIDS-deaths of members aged 20 and 40 between August 1999 and May 2000. Access to medicines and healthcare services would have saved the lives of many people. Although there are many factors that prevent equal access to health care the price of medicines is one of the most significant obstacles to healthcare in both the public and private sectors. The medicines that are needed to treat HIV/AIDS fall into two categories (a) opportunistic infection drugs (drugs that prevent or treat illnesses that occur because of HIV) and (b) anti-retroviral drugs (drugs that fight HIV directly). All anti-HIV/AIDS drugs are manufactured by multinational companies under patent and imported into South Africa. Because the drugs are patented they are very highly priced (see separate table). The result is that only the very rich and people with good medical aid coverage can access these medicines. This is the reason why, since its inception, the TAC has demanded lower drug prices from multinational companies. TAC has pressurised the drug companies through pickets, marches, meetings, parliamentary hearings, complaints to the Competition Commission and threatened legal action. Specifically, TAC requested that: · major pharmaceutical companies such as Glaxo Wellcome, Bristol-Meyers Squibb, Pfizer, Boehringer Ingelheim, Abbott, Roche provide the government with voluntary licences for generic manufacture or import of their anti-HIV/AIDS drugs; · Glaxo Wellcome, reduce the price of AZT to R180.00 for 100 X 100mg capsules; and that · Pfizer lowers it price to R4.00 for 200mg capsules of Fluconazole or grants the government a voluntary licence to produce or import generic medicines. These requests have been spurned. Meanwhile people continue to die. We believe that now is the time to intensify the campaign for access to essential drugs including life-saving HIV/AIDS drugs. We are calling on civil society organizations in South Africa and everywhere to join TAC's campaign to defy patent laws. These laws prevent people from enjoying their right to health. They amount to discrimination on the grounds of poverty. We ask you to publicly endorse the defiance of laws that place profit before people, and condemn millions to death from preventable and treatable illnesses The TAC has begun to establish a network of doctors and pharmacists who will prescribe high quality low cost generic medicines that are imported from countries such as Thailand and Brazil. The TAC challenges Pfizer, drug companies and their parent body, the Pharmaceutical Manufacturers Association to take action against us for defying their patent on fluconazole and preparing to defy patents on all HIV/AIDS drugs. TAC's Defiance Campaign will show that it is possible to save lives by taking a stand against drug company profiteering. ENDORSE THE DEFIANCE CAMPAIGN ************************************** Comparison of costs ******************* Patent Abusers and AIDS Profiteers: COMPANY MEDICINE Bristol-Meyers-Squibb ddI – didanosine Bristol-Meyers-Squibb d4T – stavudine Glaxo-Wellcome AZT – zidovudine Glaxo-Wellcome 3TC – lamivudine Glaxo-Wellcome AZT/3TC Pfizer Fluconazole Boehringer Ingelheim Nevirapine PRODUCT SA PUBLIC SECTOR SA PRIVATE SECTOR THAILAND FLUCONAZOLE R28.57 200mg capsule R80.24 X 200mg capsule R1.78 X 200mg capsule AZT R2.38 X 100mg capsule* R5.54 X 100mg capsule R2.38 X100mg capsule DDI Not available R10.90 X 150mg capsule R6.00 X 150mg capsule D4T Not available R26.00 X 40mg capsule R2.75 X 40mg capsule 3TC Not available R22.80 X 150mg capsule R16.30 X 150mg capsule *Lower cost AZT is the result of activism. The AZT price has been reduced from R5.54 in the public sector following TAC demonstations and protests. The same applies to the lower cost of Nevirapine for mtct. PRODUCT SA PUBLIC SECTOR SA PRIVATE SECTOR INDIA AZT/3TC Not available R20.00 X 300mg + 150mg R5.43 X 300mg + 150 mg NEVIRAPINE Not available R31.75 X 200mg capsule R12.00 X 200mg capsule Sources: Thai GPO and Biolab; India CIPLA; South Africa Department of Health; Private Discount Pharmacy. Valid as of 16 October 2000. These drugs and dosages are used to compare prices rather than proposed treatment regimens. *************************